Breast cancer samples were separated into two groups based on the median number of CD33+ eMDSCs infiltrated locally: lowly infiltrated eMDSCs (eMDSCslow, n = 7) and highly infiltrated eMDSCs (eMDSCshigh, n = 7). This evidence concerns the gene CD33 and breast cancer.